2015
DOI: 10.1177/0961203315585816
|View full text |Cite
|
Sign up to set email alerts
|

Electroconvulsive therapy as a treatment for refractory neuropsychiatric lupus with catatonia: three case studies and literature review

Abstract: Neuropsychiatric disorders associated with systemic lupus erythematosus are very common. Treatment generally consists of glucocorticoids and immunosuppressive therapy; however, some cases are unresponsive. Electroconvulsive therapy (ECT) is a recognized treatment modality in psychiatry and is an option for refractory cases of neuropsychiatric lupus. This report describes three cases of neuropsychiatric lupus that improved with ECT after failure of antipsychotics and immunosuppressive therapy. All cases met DSM… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 15 publications
0
1
0
1
Order By: Relevance
“…Until now, there is no published association between ECT and autoimmune disorders. ECT has been successfully used for the treatment of neuropsychiatric lupus erythematosus and autoimmune encephalitis but literature is limited to case reports and focuses on the psychiatric outcome [16,17]. The role of the immunomodulatory effects of ECT in these inflammatory disorders remains unclear.…”
Section: Variablesmentioning
confidence: 99%
“…Until now, there is no published association between ECT and autoimmune disorders. ECT has been successfully used for the treatment of neuropsychiatric lupus erythematosus and autoimmune encephalitis but literature is limited to case reports and focuses on the psychiatric outcome [16,17]. The role of the immunomodulatory effects of ECT in these inflammatory disorders remains unclear.…”
Section: Variablesmentioning
confidence: 99%
“…Evidenzlücken füllen, um Patienten eine potenziell hochwirksame und bisweilen lebensrettende Therapie nicht vorzuenthalten. Katatone Syndrome (inklusive perniziöse Katatonie und malignes neuroleptisches Syndrom) S3-Leitlinie Schizophrenie [3, [13][14][15][16] Organisch/neuropsychiatrisch bedingte Syndrome wie oben genannt [17][18][19][20][21] Therapieresistente schwere Verhaltensstörungen (z. B. schwere (Auto-)Aggression) i. R. neuropsychiatrischer Störungen, Demenzen, Autismus-Spektrum-Störungen und anderer intellektueller Entwicklungsstörungen [22][23][24][25][26][27] Autoimmunenzephalitis (mit therapieresistenten, schweren psychiatrischen Symptomen) [28] Therapierefraktäres Parkinson-Syndrom (motorische und psychiatrische Symptome) [17] Therapierefraktärer Status epilepticus [29,30] Therapieresistente delirante Syndrome (inkl.…”
unclassified